Osteoarthritis (OA) is the most common form of arthritis worldwide and is the sixth leading cause of disability. It costs the UK economy approximately 1% of gross national product per annum. With an aging population, the cost of chronic conditions such as OA continues to rise. Historically, treatments for OA have been limited to painkillers, physiotherapy and joint injections. When these fail, patients are referred for joint replacement surgery. With the advent of tissue engineering strategie...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Impact of inflammation on the osteoarthritic niche: implications for regenerative medicine.
If you are the owner of this record, you can report an update to it here: Report update to this record